Loading...
XSES
42T
Market cap71mUSD
Aug 04, Last price  
0.09SGD
Name

Trendlines Group Ltd

Chart & Performance

D1W1MN
XSES:42T chart
No data to show
P/E
P/S
11.39
EPS
Div Yield, %
Shrs. gr., 5y
-51.03%
Rev. gr., 5y
0.87%
Revenues
6m
P
13,768,00029,523,0005,952,0004,562,0007,210,0005,210,0006,236,0005,500,0003,717,0002,301,0003,578,000-20,988,0005,743,000
Net income
-34m
L-0.00%
5,827,00015,955,000-2,814,000-3,299,000-6,578,0003,863,000-6,121,000-695,000-3,951,0006,563,000-15,163,000-33,995,000-33,995,000
CFO
-9m
L+39.30%
-5,313,000-4,043,999-7,005,000-6,032,000-8,821,000-7,318,000-8,393,000-5,916,000-2,923,000650,000-14,926,000-6,343,000-8,836,000
Earnings
Apr 17, 2025

Profile

The Trendlines Group Ltd. is an innovation commercialization company and a private equity and venture capital firm specializing in incubation, seed, start-up, early venture and late venture investments. The firm seeks to invest in food, clean technology, agritechnology, lifesciences with a focus on medical devices, biotechnology, and pharmaceuticals, security, medical, and information technology companies. It considers investments in Israel and Singapore. The firm offers business incubation, partner and channel development, market strategies, business plans, research and development and commercialization activities, business development, finance and funding strategies, administrative services and marketing communications services to entrepreneurs. The firm seeks to invest a minimum of $0.06 million in its portfolio companies. The firm prefers to exit its investments through merger and acquisition transactions, listing on public stock exchanges, or other dispositions of holdings. It leverages its own capital with government funding to mitigate risk in creating and developing new businesses. It is involved in all aspects of its portfolio companies from technology development to business building. The Trendlines Group Ltd. was founded in 1993 and is based in M.P. Misgav, Israel with additional offices in Tel Aviv, Israel; Beijing, China; and Singapore, Singapore.
IPO date
Nov 26, 2015
Employees
39
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
5,743
-127.36%
(20,988)
-686.58%
3,578
55.50%
Cost of revenue
1,927
11,347
12,564
Unusual Expense (Income)
NOPBT
3,816
(32,335)
(8,986)
NOPBT Margin
66.45%
154.06%
Operating Taxes
(601)
(2,156)
Tax Rate
NOPAT
3,816
(31,734)
(6,830)
Net income
(33,995)
0.00%
(33,995)
124.20%
(15,163)
-331.04%
Dividends
Dividend yield
Proceeds from repurchase of equity
5,645
6,370
7,470
BB yield
Debt
Debt current
727
752
711
Long-term debt
4,940
5,936
6,236
Deferred revenue
888
Other long-term liabilities
15
220
(1,449)
Net debt
(65,405)
(65,831)
(87,395)
Cash flow
Cash from operating activities
(8,836)
(6,343)
(14,926)
CAPEX
(27)
(78)
(112)
Cash from investing activities
(948)
1,922
2,049
Cash from financing activities
8,645
5,966
3,133
FCF
5,015
(31,983)
(6,164)
Balance
Cash
5,892
6,110
6,565
Long term investments
65,180
66,409
87,777
Excess cash
70,785
73,568
94,163
Stockholders' equity
(38,188)
(24,745)
12,108
Invested Capital
110,385
98,685
88,081
ROIC
3.65%
ROCE
5.29%
EV
Common stock shares outstanding
18,448
18,561
840,459
Price
Market cap
EV
EBITDA
4,540
(31,550)
(8,056)
EV/EBITDA
Interest
2,041
20
5,895
Interest/NOPBT
53.49%